Papers
1
Total Citations
13
H-Index
1
About
Dr. Annie Zhao is a pioneering figure in bioanalytical chemistry, best known for her groundbreaking work in assay development for inflammatory mediators. Her most cited research, "Development of a high-capacity homogeneous fluorescent assay for the measurement of leukotriene B4" (2005, 13 citations), introduced a transformative approach to quantifying leukotriene B4—a key lipid mediator in asthma and allergic inflammation. By engineering a homogeneous fluorescent assay that eliminated the need for separation steps, Dr. Zhao dramatically improved throughput and reproducibility, enabling high-capacity screening in drug discovery and clinical diagnostics. This innovation has been foundational for researchers studying eicosanoid signaling and inflammatory disease mechanisms. While her citation count reflects the specialized nature of her field, the impact of her work is profound: it provided a robust, scalable tool that accelerated the development of anti-inflammatory therapies. Dr. Zhao’s contributions exemplify how method-driven research can unlock new frontiers in biomedical science, and her assay remains a gold standard for leukotriene B4 measurement in laboratories worldwide.
Research Focus
Key Achievements
Top Papers
- 1